|
1
|
Sakamoto A and Iwamoto Y: Current status
and perspectives regarding the treatment of osteo-sarcoma:
Chemotherapy. Rev Recent Clin Trials. 3:228–231. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mori K, Rédini F, Gouin F, Cherrier B and
Heymann D: Osteosarcoma: Current status of immunotherapy and future
trends (Review). Oncol Rep. 15:693–700. 2006.PubMed/NCBI
|
|
3
|
Loeb DM: Is there a role for immunotherapy
in osteosarcoma? Cancer Treat Res. 152:447–457. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Habel N, Hamidouche Z, Girault I,
Patiño-García A, Lecanda F, Marie PJ and Fromigué O: Zinc
chelation: A metallothionein 2A's mechanism of action involved in
osteosarcoma cell death and chemotherapy resistance. Cell Death
Dis. 4:e8742013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yanokura M, Banno K, Kobayashi Y, Kisu I,
Ueki A, Ono A, Masuda K, Nomura H, Hirasawa A, Susumu N and Aoki D:
MicroRNA and endometrial cancer: Roles of small RNAs in human
tumors and clinical applications (Review). Oncol Lett. 1:935–940.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ebert MS and Sharp PA: Roles for microRNAs
in conferring robustness to biological processes. Cell.
149:515–524. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hayes J, Peruzzi PP and Lawler S:
MicroRNAs in cancer: Biomarkers, functions and therapy. Trends Mol
Med. 20:460–469. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rogers K and Chen X: Biogenesis, turnover,
and mode of action of plant microRNAs. Plant Cell. 25:2383–2399.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu Y, Yan W, Zhang W, Chen L, You G, Bao
Z, Wang Y, Wang H, Kang C and Jiang T: MiR-218 reverses high
invasiveness of glioblastoma cells by targeting the oncogenic
transcription factor LEF1. Oncol Rep. 28:1013–1021. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang HT, Liu AG, Luo DS, Zhou ZN, Lin HG,
Chen RZ, He JS and Chen K: miR-218 expression in osteosarcoma
tissues and its effect on cell growth in osteosarcoma cells. Asian
Pac J Trop Med. 7:1000–1004. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jin J, Cai L, Liu ZM and Zhou XS:
miRNA-218 inhibits osteosarcoma cell migration and invasion by
down-regulating of TIAM1, MMP2 and MMP9. Asian Pac J Cancer Prev.
14:3681–3684. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lukas J, Petersen BO, Holm K, Bartek J and
Helin K: Deregulated expression of E2F family members induces
S-phase entry and overcomes p16INK4A-mediated growth suppression.
Mol Cell Biol. 16:1047–1057. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Infante A, Laresgoiti U, Fernández-Rueda
J, Fullaondo A, Galán J, Díaz-Uriarte R, Malumbres M, Field SJ and
Zubiaga AM: E2F2 represses cell cycle regulators to maintain
quiescence. Cell Cycle. 7:3915–3927. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Muller H, Bracken AP, Vernell R, Moroni
MC, Christians F, Grassilli E, Prosperini E, Vigo E, Oliner JD and
Helin K: E2Fs regulate the expression of genes involved in
differentiation, development, proliferation, and apoptosis. Genes
Dev. 15:267–285. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen HZ, Tsai SY and Leone G: Emerging
roles of E2Fs in cancer: An exit from cell cycle control. Nat Rev
Cancer. 9:785–797. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang T, Chen T, Niu H, Li C, Xu C, Li Y,
Huang R, Zhao J and Wu S: MicroRNA-218 inhibits the proliferation
and metastasis of esophageal squamous cell carcinoma cells by
targeting BMI1. Int J Mol Med. 36:93–102. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sui C, Xu F, Shen W, Geng L, Xie F, Dai B,
Lu J, Zhang M and Yang J: Overexpression of miR-218 inhibits
hepatocellular carcinoma cell growth through RET. Tumour Biol.
36:1511–1518. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Song L, Li D, Zhao Y, Gu Y, Zhao D, Li X,
Bai X, Sun Y, Zhang X, Sun H, et al: miR-218 suppressed the growth
of lung carcinoma by reducing MEF2D expression. Tumour Biol.
37:2891–2900. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu Z, Xu Y, Long J, Guo K, Ge C and Du R:
microRNA-218 suppresses the proliferation, invasion and promotes
apoptosis of pancreatic cancer cells by targeting HMGB1. Chin J
Cancer Res. 27:247–257. 2015.PubMed/NCBI
|
|
21
|
Jun GJ, Zhong GG and Ming ZS: miR-218
inhibits the proliferation of glioma U87 cells through the
inactivation of the CDK6/cyclin D1/p21 pathway. Oncol Lett.
9:2743–2749. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Han G, Fan M and Zhang X: microRNA-218
inhibits prostate cancer cell growth and promotes apoptosis by
repressing TPD52 expression. Biochem Biophys Res Commun.
456:804–809. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cheng Y, Yang X, Deng X, Zhang X, Li P,
Tao J and Lu Q: MicroRNA-218 inhibits bladder cancer cell
proliferation, migration, and invasion by targeting BMI-1. Tumour
Biol. 36:8015–8023. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fan R, Zhong J, Zheng S, Wang Z, Xu Y, Li
S, Zhou J and Yuan F: MicroRNA-218 inhibits gastrointestinal
stromal tumor cell and invasion by targeting KIT. Tumour Biol.
35:4209–4217. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shi J, Yang L, Wang T, Zhang J, Guo X, Huo
X and Niu H: miR-218 is downregulated and directly targets SH3GL1
in childhood medulloblastoma. Mol Med Rep. 8:1111–1117. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Iwasaki T, Tanaka K, Kawano M, Itonaga I
and Tsumura H: Tumor-suppressive microRNA-let-7a inhibits cell
proliferation via targeting of E2F2 in osteosarcoma cells. Int J
Oncol. 46:1543–1550. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pusapati RV, Weaks RL, Rounbehler RJ,
McArthur MJ and Johnson DG: E2F2 suppresses Myc-induced
proliferation and tumorigenesis. Mol Carcinog. 49:152–156.
2010.PubMed/NCBI
|
|
28
|
Zhang Y, Han D, Wei W, Cao W, Zhang R,
Dong Q, Zhang J, Wang Y and Liu N: MiR-218 inhibited growth and
metabolism of human glioblastoma cells by directly targeting E2F2.
Cell Mol Neurobiol. 35:1165–1173. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dong Y, Zou J, Su S, Huang H, Deng Y, Wang
B and Li W: MicroRNA-218 and microRNA-520a inhibit cell
proliferation by downregulating E2F2 in hepatocellular carcinoma.
Mol Med Rep. 12:1016–1022. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gao Y, Ma X, Yao Y, Li H, Fan Y, Zhang Y,
Zhao C, Wang L, Ma M, Lei Z and Zhang X: miR-155 regulates the
proliferation and invasion of clear cell renal cell carcinoma cells
by targeting E2F2. Oncotarget. 7:20324–20337. 2016.PubMed/NCBI
|
|
31
|
Li T, Luo W, Liu K, Lv X and Xi T: miR-31
promotes proliferation of colon cancer cells by targeting E2F2.
Biotechnol Lett. 37:523–532. 2015. View Article : Google Scholar : PubMed/NCBI
|
